Hólyagrák: vizsgálatok itt: Spanyolország
60 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 10.. Ask the study team whether a trial fits you.
- 1. fázisTaking peopleA Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
- Where
- Barcelona, Madrid
- Életkor
- 18 év and over
- People
- 540 worldwide
- Run by
- Pfizer
See details and how to joinNCT07090499 · EU 2025-521729-33-00 - 1. fázisTaking peopleA Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
- Where
- Barcelona, Madrid
- Életkor
- 18 év and over
- People
- 294 worldwide
- Run by
- Pfizer
See details and how to joinNCT07206225 · EU 2025-521756-39-00 - 1. fázisTaking peopleFORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
- Where
- Barcelona, Madrid, Santander
- Életkor
- 18 év and over
- People
- 677 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT05614739 · EU 2022-502755-59-00 - 1. fázisTaking peopleA Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- Where
- L'Hospitalet de Llobregat, Madrid, Sevilla
- Életkor
- 18 év and over
- People
- 460 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06465069 · EU 2024-512927-36-00 - 2. fázisTaking peopleA Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
- Where
- Barcelona, Las Palmas, Madrid, Málaga, Pamplona, Valencia
- Életkor
- 18 év and over
- People
- 200 worldwide
- Run by
- Jazz Pharmaceuticals
See details and how to joinNCT06695845 · EU 2024-516551-41-00 - 2. fázisTaking peopleA Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- Where
- Barcelona, L'Hospitalet de Llobregat, Madrid
- Életkor
- 18 év and over
- People
- 111 worldwide
- Run by
- Bayer
See details and how to joinNCT06760819 · EU 2024-517419-62-00 - 3. fázisTaking peopleA Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
- Where
- Alzira, Barcelona, Cadiz, Castillón, Jerez de la Frontera, La Coruña (A Coruña), Madrid, Málaga, Oviedo, Sabadell, Seville, Valencia
- Életkor
- 18 év and over
- People
- 641 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06319820 - 3. fázisTaking peopleA Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
- Where
- A Coruña, Barcelona, Cadiz, Castello De La Plana, Ferrol, Jerez de la Frontera, Madrid, Málaga, Sabadell, Santander
- Életkor
- 18 év and over
- People
- 220 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06919965 · EU 2024-519493-39-00 - 1. fázisTaking peopleA Study of GEN1106 in Participants With Solid Tumors
- Where
- Barcelona, Madrid
- Életkor
- 18 év and over
- People
- 103 worldwide
- Run by
- Genmab
See details and how to joinNCT07416123 · EU 2025-523760-21-00 - 3. fázisTaking peopleA Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
- Where
- Badalona, Barcelona, Las Palmas de Gran Canaria, Madrid, Santander, Sevilla
- Életkor
- 18 év and over
- People
- 590 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07419295 · EU 2024-520014-22-00 - 2. fázisTaking peoplePhase 2A/B Efficacy and Safety of Dabogratinib in Participants With Low Grade Upper Tract Urothelial Carcinoma
- Where
- Cadiz, Madrid, Santander, Sevilla, Valencia
- Életkor
- 18 év and over
- People
- 285 worldwide
- Run by
- Tyra Biosciences, Inc
See details and how to joinNCT07265947 · EU 2025-523539-20-00 - 2. fázisTaking peopleA Study to Find Out if Enfortumab Vedotin Given With Pembrolizumab Helps People With Muscle-invasive Bladder Cancer Keep Their Bladder
- Where
- Granada, Ourense, Pamplona
- Életkor
- 18 év and over
- People
- 240 worldwide
- Run by
- Astellas Pharma Global Development, Inc.
See details and how to joinNCT07475806 - 3. fázisTaking peopleTrial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
- Where
- A Coruña, Alcorcón, Barcelona, Bilbao, Córdoba, Granada, Madrid, Málaga, Santander
- Életkor
- 18 év and over
- People
- 454 worldwide
- Run by
- Ferring Pharmaceuticals
See details and how to joinNCT06510374 · EU 2024-512029-10-00 - 3. fázisTaking peopleA Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer
- Where
- A Coruña, Alcorcón, Barcelona, Bilbao, Córdoba, Madrid, Málaga, Pamplona, Santander
- Életkor
- 18 év and over
- People
- 250 worldwide
- Run by
- Ferring Pharmaceuticals
See details and how to joinNCT06545955 · EU 2024-512177-27-01 - 2/3. fázisTaking peopleDato-DXd plus Carboplatin or Cisplatin versus Gemcitabine plus Carboplatin or Cisplatin in Previously Treated la/mUC.
- Where
- Badajoz, Barcelona, Córdoba, Girona, L'Hospitalet de Llobregat, Madrid, Málaga, Pozuelo de Alarcón, Sevilla, Valencia
- Életkor
- 18 év and over
- People
- 343 worldwide
- Run by
- Daiichi Sankyo Inc.
See details and how to join2024-516906-47-00 · EU 2024-516906-47-00 - 1/2. fázisTaking peopleA Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)
- Where
- Madrid, Málaga
- Életkor
- 18 év and over
- People
- 45 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07222488 · EU 2025-520467-40-00 - 3. fázisTaking peopleEnfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
- Where
- Badalona, Barcelona, Córdoba, Lugo, Madrid, Ourense, Oviedo, Sevilla, Valencia
- Életkor
- 18 év and over
- People
- 390 worldwide
- Run by
- Astellas Pharma Global Development, Inc.
See details and how to joinNCT07566156 · EU 2026-525612-34-00 - 2. fázisTaking peopleEfficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer
- Where
- Barcelona, L'hospitalet De Llobregat, Madrid, Santander
- Életkor
- 18 év and over
- People
- 90 worldwide
- Run by
- Tyra Biosciences, Inc
See details and how to joinNCT06995677 · EU 2025-521277-14-00 - 2. fázisTaking peopleA Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Where
- Barcelona, Madrid, Málaga, Seville, Valencia
- Életkor
- 18 év and over
- People
- 740 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06172478 · EU 2023-507641-29-00 - 1/2. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Where
- Barcelona, L'Hospitalet de Llobregat, Madrid, Sevilla
- Életkor
- 18 év and over
- People
- 680 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00 - 1. fázisNot yet taking people in SpanyolországA phase I study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in patients with solid tumors
- Where
- Barcelona, L'Hospitalet de Llobregat, Madrid
- Életkor
- 18 év and over
- People
- 64 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2024-518348-19-00 · EU 2024-518348-19-00 - 1/2. fázisTaking peopleA Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9
- Where
- Barcelona, Logroño, Madrid, Pozuelo de Alarcón
- Életkor
- 18 év and over
- People
- 245 worldwide
- Run by
- BioNTech SE
See details and how to joinNCT07186842 · EU 2025-522613-26-00 - 2. fázisTaking peoplePerioperative Durvalumab With Neoadjuvant ddMVAC in Patients With Muscle-Invasive Bladder Cancer (NIAGARA-2)
- Where
- Barcelona, Girona, Las Palmas de Gran Canaria, Lugo, Madrid, Santiago de Compostela
- Életkor
- 18 év and over
- People
- 150 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06960577 · EU 2024-519246-75-01 - 1/2. fázisTaking peopleSymbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
- Where
- Barcelona, Madrid, Santander, Seville
- Életkor
- 18 év and over
- People
- 132 worldwide
- Run by
- Pfizer
See details and how to joinNCT07421700 · EU 2025-523523-21-00 - 3. fázisTaking peopleA Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
- Where
- Badajoz, Badalona, Barakaldo, Barcelona, Córdoba, Elche, Girona, Hospitalet, Las Palmas de Gran Canaria, Madrid, Málaga, Pamplona, Pozuelo de Alarcón, Reus, Santander, Santiago de Compostela, Seville, Valencia
- Életkor
- 18 év and over
- People
- 450 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07218380 · EU 2025-522855-25-00